<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="1" humanitarian="0" iati-activities:linked-data-default="http://data-service.theglobalfund.org/api" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <iati-identifier>47045-HTI-S-UGP</iati-identifier>
  <reporting-org ref="47045" secondary-reporter="0" type="30">
   <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Systemic support to Health Services in Haiti</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">Haiti - RSSH - Minist&#xE8;re de la Sant&#xE9; Publique et de la Population (Unit&#xE9; de Gestion des Projets) - UGP.  This program has the following goals: Mettre fin &#xE0; l&#x2019;&#xE9;pid&#xE9;mie de tuberculose d&apos;ici &#xE0; 2035 / Ending the tuberculosis epidemic by 2035.  Maitriser et stopper la progression de l&#x2019;&#xE9;pid&#xE9;mie de VIH au sein de la population ha&#xEF;tienne par des interventions de qualit&#xE9; qui respectent les droits et la dignit&#xE9; humaine / To control and halt the progression of the HIV epidemic in the Haitian population through quality interventions that respect human rights and dignity.  R&#xE9;duire &#xE0; z&#xE9;ro l&#x2019;incidence des cas autochtones de la malaria en Ha&#xEF;ti d&#x2019;ici d&#xE9;cembre 2025 / Reduce the incidence of indigenous cases of malaria in Haiti to zero by December 2025. The objectives of this program are: R&#xE9;duire la mortalit&#xE9; due &#xE0; la tuberculose de 18/100 000 en 2015 &#xE0; 6/100 000 d&#x2019;ici 2021 / Reduce tuberculosis mortality from 18/100,000 in 2015 to 6/100,000 by 2021.  R&#xE9;duire l&#x2019;incidence de la tuberculose de 200/100 000 en 2015 &#xE0; 165/100 000 d&#x2019;ici &#xE0; 2021 / Reduce TB incidence from 200/100,000 in 2015 to 165/100,000 by 2021.  Faire en sorte qu&#x2019;aucune famille touch&#xE9;e ne supporte de co&#xFB;ts catastrophiques li&#xE9;s &#xE0; la tuberculose / To ensure that no affected family suffers catastrophic TB-related costs.  Les nouvelles infections sont r&#xE9;duites de 90% dans la population g&#xE9;n&#xE9;rale et dans les groupes cibles prioritaires d&#x2019;ici &#xE0; 2023 / New infections are reduced by 90% in the general population and in priority target groups by 2023.  D&#x2019;ici &#xE0; fin 2023, le taux de survie &#xE0; 12 mois des enfants et adultes trait&#xE9;s par ARV atteint 90% / By the end of 2023, the 12-month survival rate of children and adults treated with ARVs reaches 90%.  D&#x2019;ici &#xE0; fin 2023, dans un environnement l&#xE9;gal d&#xE9;fini et favorable aux droits des PVVIH, la stigmatisation et la discrimination des PVVIH et des populations cl&#xE9;s a baiss&#xE9; de 80% / By the end of 2023, in a defined legal environment that is supportive of the rights of PLHIV, stigma and discrimination against PLHIV and key populations has been reduced by 80%.  100% des populations dans les zones touch&#xE9;es ont acc&#xE8;s &#xE0; un diagnostic pr&#xE9;coce soutenu par un programme d&#x2019;assurance qualit&#xE9; et ont acc&#xE8;s &#xE0; un traitement efficace sans d&#xE9;lai / 100% of populations in affected areas have access to early diagnosis supported by a quality assurance programme and have access to effective treatment without delay.  Renforcer la surveillance de la malaria et le suivi et l&apos;&#xE9;valuation du programme &#xE0; tous les niveaux, y compris au niveau institutionnel et au niveau communautaire / Strengthen malaria surveillance and programme monitoring and evaluation at all levels, including the institutional and community levels.  100% des foyers de la malaria aurait acc&#xE8;s aux mesures efficaces de protection contre la malaria / 100% of malaria outbreaks would have access to effective malaria protection measures.  Contribuer par des interventions de communication efficaces &#xE0; l&#x2019;&#xE9;limination de la transmission locale de la malaria en Ha&#xEF;ti d&#x2019;ici d&#xE9;cembre 2025 / Contribute through effective communication interventions to the elimination of local transmission of malaria in Haiti by December 2025</narrative>
  </description>
  <participating-org role="3" type="15">
   <narrative xml:lang="EN">CCM Haiti</narrative>
  </participating-org>
  <participating-org role="4" type="15">
   <narrative xml:lang="EN">CCM Haiti</narrative>
  </participating-org>
  <participating-org role="3" type="10">
   <narrative xml:lang="EN">Minist&#xE8;re de la Sant&#xE9; Publique et de la Population (Unit&#xE9; de Gestion des Projets)</narrative>
  </participating-org>
  <participating-org role="4" type="10">
   <narrative xml:lang="EN">Minist&#xE8;re de la Sant&#xE9; Publique et de la Population (Unit&#xE9; de Gestion des Projets)</narrative>
  </participating-org>
  <participating-org ref="47045" role="1" type="30">
   <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
  </participating-org>
  <other-identifier ref="54c0723c-a040-4b7a-9094-811ea4c50835" type="A1">
   <owner-org ref="47045">
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
   </owner-org>
  </other-identifier>
  <other-identifier ref="HTI-S-UGP" type="A1">
   <owner-org ref="47045">
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
   </owner-org>
  </other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2020-06-04" type="1"></activity-date>
  <activity-date iso-date="2020-06-04" type="2"></activity-date>
  <activity-date iso-date="2023-12-31" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Communications</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Murad HIRJI</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Senior Digital Architect</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>murad.hirji@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="4">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Communications</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Murad HIRJI</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Senior Digital Architect</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>murad.hirji@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Grant Management Division</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Jaime BRIZ DE FELIPE</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Fund Portfolio Manager</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>jaime.briz@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="3">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Grant Management Division</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Jaime BRIZ DE FELIPE</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Fund Portfolio Manager</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>jaime.briz@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="HT" percentage="100">
   <narrative xml:lang="EN">Haiti</narrative>
  </recipient-country>
  <sector code="12220" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">RSSH</narrative>
  </sector>
  <sector code="RSSH" percentage="100" vocabulary="99" vocabulary-uri="http://data-service.theglobalfund.org//v2.1/odata/components">
   <narrative xml:lang="EN">RSSH</narrative>
  </sector>
  <country-budget-items vocabulary="4">
   <budget-item code="0E92B28E-6628-4A93-91F4-24A0E3F68B43" percentage="2.2" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Communication Material and Publications (CMP)</narrative>
    </description>
   </budget-item>
   <budget-item code="C7B597A0-B5A0-4104-8A99-BA94F1C26180" percentage="10.95" vocabulary="4">
    <description>
     <narrative xml:lang="EN">External Professional services (EPS)</narrative>
    </description>
   </budget-item>
   <budget-item code="1BDFF48D-DF9D-43D5-BCDF-56FECE799046" percentage="2.72" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Health Products - Equipment (HPE)</narrative>
    </description>
   </budget-item>
   <budget-item code="AEEC85E4-0556-495F-8F31-584DD9FF4EF3" percentage="6.85" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Human Resources (HR)</narrative>
    </description>
   </budget-item>
   <budget-item code="400CEE75-C251-4A85-AA43-BD93DF71A408" percentage="3.78" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Indirect and Overhead Costs</narrative>
    </description>
   </budget-item>
   <budget-item code="FDEDB289-7073-424F-8780-856D2FB8F704" percentage="6.98" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Infrastructure (INF)</narrative>
    </description>
   </budget-item>
   <budget-item code="8FF157DA-C279-44D8-8148-6161B33C9E92" percentage="7.51" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Non-health equipment (NHP)</narrative>
    </description>
   </budget-item>
   <budget-item code="DC588E6C-6B65-46A8-90D7-3ACCD004E54D" percentage="20.51" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Procurement and Supply-Chain Management costs (PSM)</narrative>
    </description>
   </budget-item>
   <budget-item code="F4B643AF-C501-4424-B4BD-74AA0DA9F006" percentage="38.5" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Travel related costs (TRC)</narrative>
    </description>
   </budget-item>
  </country-budget-items>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-03-31"></period-end>
   <value currency="USD" value-date="2021-01-01">2150578</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-04-01"></period-start>
   <period-end iso-date="2021-06-30"></period-end>
   <value currency="USD" value-date="2021-01-01">2227839</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-07-01"></period-start>
   <period-end iso-date="2021-09-30"></period-end>
   <value currency="USD" value-date="2021-01-01">2625916</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-10-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="USD" value-date="2021-01-01">2095386</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-03-31"></period-end>
   <value currency="USD" value-date="2021-01-01">5573293</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-04-01"></period-start>
   <period-end iso-date="2022-06-30"></period-end>
   <value currency="USD" value-date="2021-01-01">2704588</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-07-01"></period-start>
   <period-end iso-date="2022-09-30"></period-end>
   <value currency="USD" value-date="2021-01-01">833782</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-10-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2021-01-01">885579</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-01-01"></period-start>
   <period-end iso-date="2023-03-31"></period-end>
   <value currency="USD" value-date="2021-01-01">13750266</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-04-01"></period-start>
   <period-end iso-date="2023-06-30"></period-end>
   <value currency="USD" value-date="2021-01-01">915367</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-07-01"></period-start>
   <period-end iso-date="2023-09-30"></period-end>
   <value currency="USD" value-date="2021-01-01">559144</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-10-01"></period-start>
   <period-end iso-date="2023-12-31"></period-end>
   <value currency="USD" value-date="2021-01-01">555778</value>
  </budget>
  <capital-spend percentage="2.72"></capital-spend>
  <transaction ref="c343abb0-580f-433a-935b-80831b4afe8b">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-22"></transaction-date>
   <value currency="USD" value-date="2021-01-22">17377590.35</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to HTI-S-UGP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">Minist&#xE8;re de la Sant&#xE9; Publique et de la Population (Unit&#xE9; de Gestion des Projets)</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="ebccf3b6-c157-4137-8f5f-d093fd155a73">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-05"></transaction-date>
   <value currency="USD" value-date="2021-02-05">1836696.97</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to HTI-S-UGP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">Minist&#xE8;re de la Sant&#xE9; Publique et de la Population (Unit&#xE9; de Gestion des Projets)</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="32dfc1ee-667d-414f-bd9e-8663df9c49fe">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-09"></transaction-date>
   <value currency="USD" value-date="2021-04-09">128000</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to HTI-S-UGP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">Minist&#xE8;re de la Sant&#xE9; Publique et de la Population (Unit&#xE9; de Gestion des Projets)</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="a29a7a3d-d176-4538-ae9b-fd14bdb7020e">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-23"></transaction-date>
   <value currency="USD" value-date="2021-04-23">185881</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to HTI-S-UGP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">Minist&#xE8;re de la Sant&#xE9; Publique et de la Population (Unit&#xE9; de Gestion des Projets)</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <result aggregation-status="0" type="2">
   <title>
    <narrative xml:lang="EN">Outcome indicator for HTI-S-UGP</narrative>
   </title>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">HSS O-Other 4: Notification of RR-TB and/or MDR-TB cases &#x2013; Percentage of notified cases of bacteriologically confirmed, drug resistant RR-TB and/or MDR-TB as a proportion of all estimated RR-TB and/or MDR-TB cases</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 152 Denominator: 547.22 Percentage: 69.00</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2021-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 255 Denominator: 525 Percentage: 48.57</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 283 Denominator: 514 Percentage: 55.06</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 300 Denominator: 477 Percentage: 62.89</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">HSS O-Other 5: Annual blood examination rate: per 100 population per year (Elimination settings)</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 266675 Denominator: 1.1683E+07 Percentage: 2.28</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2021-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 374598 Denominator: 1.215674E+07 Percentage: 3.08</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 525408 Denominator: 8132649 Percentage: 6.46</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 509495 Denominator: 6992324 Percentage: 7.29</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">HSS O-Other 2: Percentage of people living with HIV and on ART who are virologically suppressed</narrative>
    </title>
    <baseline year="2019">
     <dimension name="Gender" value="Male"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 22807 Denominator: 28321 Percentage: 80.53</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender" value="Female"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 38234 Denominator: 47476 Percentage: 80.53</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 62094 Denominator: 77796 Percentage: 79.82</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2021-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 101689 Denominator: 119634 Percentage: 85.00</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 116854 Denominator: 129838 Percentage: 90.00</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 130498 Denominator: 137366 Percentage: 95.00</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">HSS O-Other 1: Percentage of health facilities with tracer medicines for the three diseases available on the day of the visit or day of reporting</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 121229 Denominator: 160000 Percentage: 75.77</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender" value="Male"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 42670 Denominator: 58486 Percentage: 72.96</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender" value="Female"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 71382 Denominator: 85400 Percentage: 83.59</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2021-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 142421 Denominator: 158246 Percentage: 90.00</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 148341 Denominator: 159506 Percentage: 93.00</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 152629 Denominator: 160662 Percentage: 95.00</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">National aggregate HMIS fully deployed and functional: Percentage of HMIS components in place (HIS deployment, completeness, timeliness, and integration of aggregate disease reporting for HIV, TB and malaria indicators)</narrative>
    </title>
    <baseline year="2020">
     <comment>
      <narrative xml:lang="EN">Percentage: 62.00</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2021-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 77.00</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 89.00</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 100.00</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">HSS O-Other-3: TB treatment coverage: Percentage of new and relapse cases that were notified and treated among the estimated number of incident TB cases in the same year (all form of TB - bacteriologically confirmed plus clinically diagnosed)</narrative>
    </title>
    <baseline year="2018">
     <comment>
      <narrative xml:lang="EN">Percentage: 69.00</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2021-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 77.00</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 82.00</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 87.00</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">HSS O-Other-6: Percentage of CHWs who benefit from a supportive supervision during the period and comply with minimum requirements in terms of equipment, materials and knowledge/practices</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2021-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 1432 Denominator: 4774 Percentage: 30.00</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 2569 Denominator: 5137 Percentage: 50.00</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 4400 Denominator: 5500 Percentage: 80.00</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">Coverage / Output indicator for HTI-S-UGP</narrative>
   </title>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Completeness of facility reporting: Percentage of expected facility monthly reports (for the reporting period) that are actually received</narrative>
    </title>
    <baseline year="2019">
     <dimension name="Type of report" value="Integrated reports"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 10019 Denominator: 10512 Percentage: 95.31</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 10019 Denominator: 10512 Percentage: 95.31</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Timeliness of facility reporting: Percentage of submitted facility monthly reports (for the reporting period) that are received on time per the national guidelines</narrative>
    </title>
    <baseline year="2019">
     <dimension name="Type of report" value="Integrated reports"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 3688 Denominator: 10512 Percentage: 35.08</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 3688 Denominator: 10512 Percentage: 35.08</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">LAB Other-2 Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy (TB, Malaria), RDTs (HIV) and VL (HIV) among the total number of laboratories that undertake these tests during the reporting period</narrative>
    </title>
    <baseline year="2020">
     <comment>
      <narrative xml:lang="EN">Numerator: 484 Denominator: 597 Percentage: 81.07</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of health facilities with tracer medicines for the three diseases available on the day of the visit or day of reporting</narrative>
    </title>
    <baseline year="2020">
     <comment>
      <narrative xml:lang="EN">Percentage: 78.00</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of health facilities providing diagnostic services with tracer items available on the day of the visit or day of reporting</narrative>
    </title>
    <baseline year="2020">
     <comment>
      <narrative xml:lang="EN">Percentage: 89.00</narrative>
     </comment>
    </baseline>
   </indicator>
  </result>
  <result aggregation-status="0" type="3">
   <title>
    <narrative xml:lang="EN">Impact indicator for HTI-S-UGP</narrative>
   </title>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">HSS I-Other 2: Number of new HIV infections per 1000 uninfected population</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 0.4729666</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2021-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 0.37</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 0.33</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 0.28</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">HSS I-Other 5: Annual parasite incidence: Confirmed malaria cases (microscopy or RDT): rate per 1000 persons per year (Elimination settings)</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 0.91</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2021-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 0.51</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 0.43</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 0.19</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">HSS I-Other 3: TB incidence rate per 100,000 population</narrative>
    </title>
    <baseline year="2018">
     <comment>
      <narrative xml:lang="EN">Numerator: 176</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2021-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 147</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 141</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 136</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">HSS I-Other 1: Number of AIDS-related deaths per 100,000 population</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 21.85827</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2021-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 14.53</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 12.66</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 11.33</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">HSS I-Other 4: TB mortality rate per 100,000 population</narrative>
    </title>
    <baseline year="2018">
     <comment>
      <narrative xml:lang="EN">Numerator: 9.222364</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2021-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 6.6</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 6.5</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 5.8</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
